PWMG
REGN icon

Prestige Wealth Management Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Prestige Wealth Management Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39.3K Hold
63
– – 0.01% 291
2026
Q1 		$48.7K Buy
63
+2
+3% +$1.53K 0.01% 260
2025
Q4 		$47.1K Sell
61
-20
-25% -$13.6K 0.01% 259
2025
Q3 		$45.5K Sell
81
-6
-7% -$3.39K 0.01% 274
2025
Q2 		$45.7K Sell
87
-3
-3% -$1.67K 0.01% 265
2025
Q1 		$57.1K Sell
90
-11
-11% -$7.57K 0.01% 236
2024
Q4 		$71.9K Buy
101
+19
+23% +$15.9K 0.02% 226
2024
Q3 		$86.2K Sell
82
-20
-20% -$22.3K 0.02% 205
2024
Q2 		$107K Sell
102
-49
-32% -$47.5K 0.02% 173
2024
Q1 		$145K Sell
151
-16
-10% -$15.2K 0.03% 173
2023
Q4 		$147K Sell
167
-5
-3% -$4.12K 0.03% 155
2023
Q3 		$142K Buy
172
+3
+2% +$2.36K 0.03% 157
2023
Q2 		$121K Sell
169
-292
-63% -$225K 0.03% 190
2023
Q1 		$379K Buy
461
+293
+174% +$221K 0.1% 100
2022
Q4 		$121K Sell
168
-11
-6% -$8.12K 0.03% 172
2022
Q3 		$124K Sell
179
-2
-1% -$1.26K 0.03% 159
2022
Q2 		$107K Buy
181
+6
+3% +$3.9K 0.03% 171
2022
Q1 		$122K Sell
175
-293
-63% -$185K 0.03% 173
2021
Q4 		$295K Buy
468
+118
+34% +$72.5K 0.07% 113
2021
Q3 		$212K Buy
350
+219
+167% +$136K 0.05% 132
2021
Q2 		$73K Sell
131
-4
-3% -$2.03K 0.02% 207
2021
Q1 		$64K Buy
135
+42
+45% +$20.4K 0.02% 225
2020
Q4 		$45K Sell
93
-88
-49% -$47.5K 0.01% 259
2020
Q3 		$101K Buy
181
+32
+21% +$19.4K 0.03% 173
2020
Q2 		$93K Buy
149
+99
+198% +$56.2K 0.03% 159
2020
Q1 		$24K Hold
50
– – 0.01% 256
2019
Q4 		$19K Hold
50
– – 0.01% 299
2019
Q3 		$14K Hold
50
– – 0.01% 313
2019
Q2 		$16K Hold
50
– – 0.01% 293
2019
Q1 		$21K Sell
50
-34
-40% -$14K 0.01% 274
2018
Q4 		$31K Buy
+84
New +$30.7K 0.02% 246

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Prestige Wealth Management Group's REGN Position: Q2 2026 in Review

Prestige Wealth Management Group held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 63 shares worth $39.3K. The position accounts for 0.01% of the portfolio, ranked #291.

Prestige Wealth Management Group first reported a position in REGN in Q4 2018 and has held it in 31 quarters since. The position peaked at $379K in Q1 2023. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Prestige Wealth Management Group held 63 shares of Regeneron Pharmaceuticals worth $39.3K as of Q2 2026.
  • Prestige Wealth Management Group left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
  • Regeneron Pharmaceuticals made up 0.01% of Prestige Wealth Management Group's portfolio in Q2 2026, its #291 holding.
  • Prestige Wealth Management Group first reported a position in Regeneron Pharmaceuticals in Q4 2018 and has held it in 31 quarters since.
  • Prestige Wealth Management Group's Regeneron Pharmaceuticals position peaked at $379K in Q1 2023.
  • 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Prestige Wealth Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.